The Link Between Blood Inflammation Levels and Diabetic Nephropathy
Did you know that a simple blood test could hold the key to understanding a serious complication of diabetes? Recent research has uncovered a striking connection between an elevated neutrophil to lymphocyte ratio (NLR) and the development as well as progression of diabetic nephropathy. This important finding comes from an extensive meta-analysis that evaluated the prognostic significance of NLR across various stages of this debilitating disease.
Understanding Diabetic Nephropathy and the Study Methodology
Diabetic nephropathy is a critical condition that significantly contributes to chronic kidney disease and increased mortality rates among individuals with diabetes. This situation emphasizes the urgent need for easily accessible biomarkers to help identify patients at risk early on. The neutrophil to lymphocyte ratio, which can be derived from regular blood tests, has garnered attention as a potential indicator of systemic inflammation. However, its predictive capabilities throughout the spectrum of diabetic nephropathy have remained somewhat ambiguous. To clarify this relationship, researchers systematically reviewed and conducted a meta-analysis of cohort and case-control studies published until May 28, 2025. They collected and analyzed data using odds ratios (OR) and standardized mean differences (SMD), while also performing subgroup and sensitivity analyses to address any inconsistencies in the data. This review was officially registered in the PROSPERO database to ensure transparency.
NLR and the Occurrence of Diabetic Nephropathy
Involving 39 studies and over 14,300 participants, the findings revealed that individuals with diabetic nephropathy exhibited significantly elevated NLR values compared to those with diabetes but without nephropathy. The correlation between NLR and disease occurrence was both consistent and strong, showing an SMD of 1.31 (95% CI: 0.96–1.66; p<0.00001) and an OR of 2.16 (95% CI: 1.85–2.52; p<0.00001). These statistics suggest that a higher NLR is associated with more than double the likelihood of developing diabetic nephropathy, thereby reinforcing its potential as an inflammatory biomarker in everyday clinical evaluations.
Implications for Disease Progression and Mortality
Among those diagnosed with diabetic nephropathy, higher levels of NLR were also linked to a decline in kidney function compared to patients who maintained stable disease conditions. The findings illustrated an SMD of 1.02 (95% CI: 0.77–1.26; p<0.00001) and an OR of 2.12 (95% CI: 1.04–4.31; p=0.04). Interestingly, while there was a noted association with overall mortality, it did not achieve statistical significance, presenting an OR of 1.21 (95% CI: 0.99–1.48; p=0.06). Furthermore, subgroup analyses indicated stronger correlations in older adults (aged 60 years or more) and those with a body mass index of 25 kg/m² or greater. Although these results position the NLR as a promising tool for identifying patients at higher risk concerning the onset and advancement of diabetic nephropathy, the authors cautioned that variability in the data and potential publication bias necessitate careful interpretation. Larger, standardized studies are required to validate these findings.
Reference
Liu H et al. The predictive value of neutrophil-to-lymphocyte ratio for the occurrence, progression, and mortality of diabetic nephropathy: a systematic review and meta-analysis. Scientific Reports. 2026; https://doi.org/10.1038/s41598-025-30680-4.
Author:
This article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/).
